MED12 and colorectal carcinoma: Similar results were recently reported by Je et al and The Cancer Genome Atlas Network, both of whom found one MED12 exon 2 mutation in 389 (0.3%) and 224 (0.4%) CRC samples, respectively (Je et al, 2012; The Cancer Genome Atlas Network, 2012).